Capital World Investors Buys 1,419,575 Shares of CVS Health Corporation $CVS

Capital World Investors increased its position in CVS Health Corporation (NYSE:CVS) by 2.1% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 68,382,158 shares of the pharmacy operator’s stock after buying an additional 1,419,575 shares during the period. Capital World Investors owned 0.05% of CVS Health worth $5,155,380,000 at the end of the most recent quarter.

Several other institutional investors have also added to or reduced their stakes in the company. Harbor Capital Advisors Inc. raised its holdings in shares of CVS Health by 72.1% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 339 shares of the pharmacy operator’s stock worth $26,000 after acquiring an additional 142 shares in the last quarter. Corundum Trust Company INC bought a new stake in CVS Health in the third quarter worth $29,000. Front Row Advisors LLC raised its stake in CVS Health by 436.5% during the second quarter. Front Row Advisors LLC now owns 456 shares of the pharmacy operator’s stock valued at $31,000 after purchasing an additional 371 shares in the last quarter. Twin Peaks Wealth Advisors LLC bought a new position in CVS Health during the second quarter valued at $36,000. Finally, SOA Wealth Advisors LLC. raised its position in shares of CVS Health by 36.9% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 486 shares of the pharmacy operator’s stock valued at $37,000 after buying an additional 131 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on CVS. Leerink Partners reissued an “outperform” rating and set a $98.00 price objective on shares of CVS Health in a research note on Thursday. Argus decreased their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Wolfe Research cut their price objective on shares of CVS Health from $100.00 to $97.00 and set an “outperform” rating on the stock in a research report on Monday, March 2nd. Robert W. Baird lifted their price target on shares of CVS Health from $82.00 to $92.00 and gave the stock an “outperform” rating in a research note on Wednesday, December 10th. Finally, Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a research note on Monday, December 29th. Nineteen research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. According to MarketBeat, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $94.91.

CVS Health Price Performance

NYSE CVS opened at $78.25 on Tuesday. The company has a market cap of $99.55 billion, a PE ratio of 56.70, a P/E/G ratio of 0.81 and a beta of 0.49. CVS Health Corporation has a 52-week low of $58.35 and a 52-week high of $85.15. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.63 and a current ratio of 0.84. The firm’s 50 day moving average price is $78.46 and its 200-day moving average price is $77.70.

CVS Health (NYSE:CVS) last issued its quarterly earnings data on Tuesday, February 10th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same quarter last year, the company earned $1.19 earnings per share. The firm’s revenue for the quarter was up 8.2% compared to the same quarter last year. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Sell-side analysts forecast that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Monday, February 2nd. Stockholders of record on Thursday, January 22nd were paid a dividend of $0.665 per share. The ex-dividend date was Thursday, January 22nd. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.4%. CVS Health’s payout ratio is presently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.